Carolyn was on the brink of death. Her recovery has doctors ‘shooting for a cure’
Carolyn McGrath, diagnosed with multiple myeloma over a decade ago, faced a grim prognosis after numerous treatments failed. A clinical trial involving a new immunotherapy drug, Elranatamab, led to significant improvements for many patients, including McGrath, who achieved remission. This breakthrough has made the drug accessible to more Australians, offering hope to those with limited options.
- ▪Carolyn McGrath was diagnosed with multiple myeloma in 2014 and underwent various treatments.
- ▪She participated in a clinical trial for a drug called Elranatamab, which resulted in her remission.
- ▪Over 60 percent of trial participants experienced cancer shrinkage, with 35 percent achieving undetectable levels of the disease.
Sydney Morning Herald publishes from Australia and files mainly under world. We currently carry 3,705 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Sydney Morning Herald |
| Canonical URL | https://www.smh.com.au/healthcare/carolyn-was-on-the-brink-of-death-her-recovery-has-doctors-shooting-for-a-cure-20260520-p5zyz2.html?ref=rss&utm_medium=rss&utm_source=rss_feed |
| Publication time | Fri, 22 May 2026 19:00:00 +1000 |
| Retrieval time | 2026-05-22T09:07:01.166Z |
| Last seen | 2026-05-22T09:07:01.166Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | sq8wMKETWOKo |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","dateModified":"2026-05-22T09:00:00Z","datePublished":"2026-05-22T09:00:00Z","description":"Carolyn McGrath went through years of gruelling treatments, but the blood cancer always came back. Then a new drug trialled in Melbourne saved her life.","headline":"Carolyn was on the brink of death. Her recovery has doctors ‘shooting for a cure’","keywords":"Healthcare, Just in, For subscribers, Cancer","author":[{"@type":"Person","name":"Melissa Cunningham","jobTitle":"Health…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Sydney Morning Herald.